Curis (CRIS) Revenue (2010 - 2025)
Curis (CRIS) reported Revenue of $1.1 million for Q4 2025, down 65.98% on a YoY basis from $3.3 million in Q4 2024, and down 64.17% quarter-over-quarter from $3.2 million in Q3 2025.
Curis (CRIS) Revenue (2010 - 2025) Analysis & Trends
Curis has reported Revenue for 16 years, with the latest figure at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Revenue fell 65.98% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (down 36.95% YoY), and the FY2025 full-year result was $9.4 million, down 13.43% from the prior year.
- Revenue for Q4 2025 stood at $1.1 million, down from $3.2 million in the prior quarter.
- The five-year high for Revenue was $3.3 million in Q4 2024, with the low at $1.1 million in Q4 2025.
- Historically, Revenue has averaged $2.6 million across 5 years, with a median of $2.6 million in 2023.
- Annual changes were most pronounced in 2024 — Revenue gained 24.07% — and 2025, when it sank 65.98%.
- Curis' Revenue stood at $3.1 million in 2021, then slipped by 7.91% to $2.9 million in 2022, then fell by 6.62% to $2.7 million in 2023, then grew by 24.07% to $3.3 million in 2024, then slumped by 65.98% to $1.1 million in 2025.
- The last three Revenue figures came in at $1.1 million (Q4 2025), $3.2 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Curis | 9.17 Mn | -5.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 3.35 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.89 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.06 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 3.04 Mn |
| Jun 30, 2021 | 2.29 Mn |
| Mar 31, 2021 | 2.19 Mn |